董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Raluca Dinu | 女 | Director | 48 | 79.09万美元 | 未持股 | 2022-11-15 |
| Avi S. Katz | 男 | Chairman of the Board | 64 | 未披露 | 未持股 | 2022-11-15 |
| Agnes Rey Giraud | 女 | Director | 58 | 65.31万美元 | 未持股 | 2022-11-15 |
| Samuel J. Meckey | 男 | Director and CEO | 52 | 未披露 | 未持股 | 2022-11-15 |
| Nathan Locke | 男 | Director | 40 | 36.26万美元 | 未持股 | 2022-11-15 |
| Mariya Pylypiv | 女 | Director | 34 | 103.88万美元 | 未持股 | 2022-11-15 |
| Chirinjeev Kathuria | 男 | Director | 57 | 56.04万美元 | 未持股 | 2022-11-15 |
| Avi S. Katz | 男 | Chairman of the Board | 65 | 68.14万美元 | 未持股 | 2022-11-15 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Samuel J. Meckey | 男 | Director and CEO | 52 | 未披露 | 未持股 | 2022-11-15 |
| Ramesh Balakrishnan | 男 | President and Chief Strategy Officer | 68 | 2273.31万美元 | 未持股 | 2022-11-15 |
| Martin S. A. Beck | 男 | Chief Financial Officer | 56 | 156.80万美元 | 未持股 | 2022-11-15 |
董事简历
中英对照 | 中文 | 英文- Raluca Dinu
-
Raluca Dinu自2024年3月起担任首席执行官、总裁、秘书，并担任QT Imaging Holdings，Inc.（OTCQB：QTIH）的董事，自2021年2月由她和Katz博士以GIG5的身份创立以来。Dinu博士在TMT行业的国际高管岗位上工作了大约21年，曾为私营初创企业、中型公司和大型企业工作。在这些角色中，Dinu博士在启动和加速实体、建立团队、大规模筹资、发展关键联盟和技术伙伴关系、并购活动、业务发展、财务管理、全球运营以及销售和营销方面发挥了重要作用。Katz和Dinu还共同创立了GigInternational1，Inc.，这是一家私人对公共股权（PPE）公司，其成立的目的是收购TMT、A & D、移动和半导体行业的一家公司，尤其侧重于欧洲、中东和非洲市场。GigInternational1于2021年5月完成首次公开募股，Dinu博士从GigInternational1成立之初就担任董事，并于2021年3月开始担任GigInternational1的首席执行官、总裁和秘书。2022年11月，GigInternational1决定对公司进行清算解散而不是进行企业合并，并于2022年12月，GigInternational1在清算其信托账户后从纳斯达克退市。Dinu博士还持有GigManagement，LLC 50%的会员权益，自GigManagement，LLC成立以来一直担任管理成员。2017年4月至2019年5月，Dinu博士担任IDT（纳斯达克：IDTI）副总裁兼Optical Interconnects Division总经理。PHE还拥有Harvard商学院的公司董事证书，这是在2021年完成了审计委员会和薪酬委员会的认证并在2022年使公司董事会更加有效之后。Dinu博士与Gigcapital8 Corp.董事会主席Katz博士结婚。
Raluca Dinu serves as one of directors and co founded Company with Dr. Avi S. Katz, who is Chief Executive Officer and Chairman, of the Board of Directors since May 2024. Dr. Dinu has spent approximately 21 years in international executive positions within the TMT indtry working for privately held start ups, middle cap companies and large enterprises. She has also served as a member of the board of directors of BigBear.ai Holdings, Inc. since its inception in December 2020 as GIG4 until March 2024, and prior to the December 2021 biness combination, was also the President, Chief Executive Officer and Secretary of GIG4 since its inception in December 2020. From February 2014 to September 2017, Dr. Dinu was a member of the board of directors of Brazil Photonics, in Campinas, Brazil, a joint venture that GigPeak established with the Centro de Pesquisa e Desenvolvimento em Telecomunicaes (CPqD). From 2001 to 2008, Dr. Dinu was Vice President of Engineering at Lumera (Nasdaq: LMRA). Lumera was acquired by GigPeak in 2008, and Dr. Dinu joined GigPeak at that time. Dr. Dinu holds a B.Sc. in Physics and Ph.D. in Solid State Condensed Matter Physics from the University of Bucharest, and an Executive M.B.A. from Stanford University. She also has a Corporate Director certificate from Harvard Biness School, after completing the certification for Audit Committees and Compensation Committees in 2021 and Making Corporate Boards More Effective in 2022. - Raluca Dinu自2024年3月起担任首席执行官、总裁、秘书，并担任QT Imaging Holdings，Inc.（OTCQB：QTIH）的董事，自2021年2月由她和Katz博士以GIG5的身份创立以来。Dinu博士在TMT行业的国际高管岗位上工作了大约21年，曾为私营初创企业、中型公司和大型企业工作。在这些角色中，Dinu博士在启动和加速实体、建立团队、大规模筹资、发展关键联盟和技术伙伴关系、并购活动、业务发展、财务管理、全球运营以及销售和营销方面发挥了重要作用。Katz和Dinu还共同创立了GigInternational1，Inc.，这是一家私人对公共股权（PPE）公司，其成立的目的是收购TMT、A & D、移动和半导体行业的一家公司，尤其侧重于欧洲、中东和非洲市场。GigInternational1于2021年5月完成首次公开募股，Dinu博士从GigInternational1成立之初就担任董事，并于2021年3月开始担任GigInternational1的首席执行官、总裁和秘书。2022年11月，GigInternational1决定对公司进行清算解散而不是进行企业合并，并于2022年12月，GigInternational1在清算其信托账户后从纳斯达克退市。Dinu博士还持有GigManagement，LLC 50%的会员权益，自GigManagement，LLC成立以来一直担任管理成员。2017年4月至2019年5月，Dinu博士担任IDT（纳斯达克：IDTI）副总裁兼Optical Interconnects Division总经理。PHE还拥有Harvard商学院的公司董事证书，这是在2021年完成了审计委员会和薪酬委员会的认证并在2022年使公司董事会更加有效之后。Dinu博士与Gigcapital8 Corp.董事会主席Katz博士结婚。
- Raluca Dinu serves as one of directors and co founded Company with Dr. Avi S. Katz, who is Chief Executive Officer and Chairman, of the Board of Directors since May 2024. Dr. Dinu has spent approximately 21 years in international executive positions within the TMT indtry working for privately held start ups, middle cap companies and large enterprises. She has also served as a member of the board of directors of BigBear.ai Holdings, Inc. since its inception in December 2020 as GIG4 until March 2024, and prior to the December 2021 biness combination, was also the President, Chief Executive Officer and Secretary of GIG4 since its inception in December 2020. From February 2014 to September 2017, Dr. Dinu was a member of the board of directors of Brazil Photonics, in Campinas, Brazil, a joint venture that GigPeak established with the Centro de Pesquisa e Desenvolvimento em Telecomunicaes (CPqD). From 2001 to 2008, Dr. Dinu was Vice President of Engineering at Lumera (Nasdaq: LMRA). Lumera was acquired by GigPeak in 2008, and Dr. Dinu joined GigPeak at that time. Dr. Dinu holds a B.Sc. in Physics and Ph.D. in Solid State Condensed Matter Physics from the University of Bucharest, and an Executive M.B.A. from Stanford University. She also has a Corporate Director certificate from Harvard Biness School, after completing the certification for Audit Committees and Compensation Committees in 2021 and Making Corporate Boards More Effective in 2022.
- Avi S. Katz
-
AviS.Katz自2019年3月起担任我们的董事会执行主席，从那时起至2019年8月，他还担任我们的首席执行官，总裁兼秘书。自2020年2月起，他还担任GigCapital3Inc.的董事会执行主席，首席执行官，总裁兼秘书。他也是GigFounders，LLC的创始管理成员，以及我们赞助商的经理，以及GigAcquisitions，LLC GigCapital and GigAcquisitions3LLC（GigCapital3Inc.的赞助商）的赞助商。Katz博士在TMT行业担任了近32年的国际执行职位，为私人持有的初创企业，中型公司和大型企业工作。在担任这些职务期间，卡茨博士在建立和加速实体、建立团队、大规模筹资、发展关键联盟和技术伙伴关系、并购活动、企业发展、财务管理、全球业务和销售与市场营销等方面发挥了重要作用。2017年10月，Katz博士创立了GigCapital，这是一家为收购科技行业公司而成立的私募股权（PPE）公司。GigCapital于2017年12月完成了首次公开募股，其中以每单位10.00美元的价格出售了14375000股，每单位由一股GigCapital普通股组成，购买一股GigCapital普通股的认股权证的四分之三（3/4）和获得一股GigCapital普通股的十分之一（1/10）的权利，产生的总收益为143750000美元，当时在纽约证券交易所上市，股票代码为“；GIG。在对全球400多家公司进行了密集筛选后，GigCapital于2019年2月22日签订了一项股票购买协议，以交易企业价值1.87亿美元的价格收购Kaleyra S.p.A.，合并现金和/或本票对价为1500万美元。Kaleyra S.p.A.是一家全球性公司，专门为金融机构和各种规模的公司提供移动消息服务。交易于2019年11月25日完成，GigCapital更名为Kaleyra，Inc.，并在当时的纽约证券交易所美国证券交易所上市，股票代码为“；KLR”；。自2019年11月交易完成以来，Katz博士一直担任Kaleyra，Inc.的执行主席。他也是GigCapital3Inc.的创始人，董事会执行主席兼首席执行官，自2020年2月在特拉华州注册成立以来。Katz博士还是Cognizer，Inc.（人工智能（“；AI”；）公司的联合创始人，并从2018年12月成立至2020年8月担任其董事会执行主席，该公司拥有基于深度学习的自然语言理解平台。此前，Katz博士致力于开发和管理Gigpeak（NYSE American:前身为GIG），原名为Gigoptix，Inc.，历时10年。从2007年4月成立到2017年4月出售，Gigpeak为高速连接和视频压缩提供半导体集成电路（IC）和软件解决方案。在Katz博士掌舵Gigpeak&8217；期间，该公司完成了10笔并购交易。Gigpeak于2017年4月以2.5亿美元的现金出售给Integrated DeviceTechnology，Inc.（NASDAQ:IDTI）。从2003年到2005年，Katz博士担任Intransa，Inc.的首席执行官，总裁兼董事会成员，该公司当时提供全功能，基于企业级IP的存储区域网（SAN）。从2000年到2003年，Katz博士担任Equator Technologies的首席执行官。Equator Technologies寻求将领先的可编程媒体处理平台技术商业化，以快速设计和部署数字媒体和成像产品。Equator Technologies于2005年以1.1亿美元的价格出售给Pixelworks，Inc.。Katz博士在其30多年的科技行业职业生涯中担任过多个领导职位，并对世界各地的高科技公司进行过众多天使投资。此外，Katz博士是以色列海军学院（Israeli Naval Academy）的毕业生，并持有学士学位。以及the Technion（以色列理工学院）半导体材料博士学位。他是TMT领域的连续企业家和长期天使投资人，持有70多项美国和国际专利，发表了大约300篇技术论文，是多本技术书籍的编辑。
Avi S. Katz erved as GigCapital, Inc. formerly NYSE: GIG Founder, Executive Chairman of the Board, Chief Executive Officer, President and Secretary since October 2017 and upon the closing of the Business Combination, when GigCapital, Inc. renamed itself Kaleyra, Inc., Dr. Katz transitioned to be the Executive Chairman of our Board of Directors of Kaleyra, Inc. (NYSE: KLR). Dr. Katz has spent approximately 34 years in international executive positions within the technology, media and telecommunications (TMT) industry working for privately held start-ups, middle-cap companies and large enterprises. In these roles, Dr. Katz has been instrumental in launching and accelerating entities, building teams, large scale fund-raising, developing key alliances and technology partnerships, domestic and international M&A activities, business development, financial management, global operations and sales and marketing. Dr. Katz is the Founder and Sole Founding Manager of GigCapital Global (GigCG), which he incepted in 2017 and its affiliated entities, including GigAcquisitions, LLC, GigAcquisitions2 LLC, GigAcquisitions3 LLC, GigAcquisitions4 LLC, GigAcquisitions5 LLC, GigAcquisitions6 LLC and GigInternational1 Sponsor, LLC, all of which are sponsors to Private-to-Public Equity (PPE) companies which have been formed for the purpose of acquiring companies in the technology industry. GigCG is an inceptor and managing group of Private-to-Public Equity (PPE) entities, also known as a blank check company or special purpose acquisition company (SPAC) vehicles. Following the inception of GigCapital, inc., in March 2019 Dr. Katz founded GigCapital2 Inc. ("GIG2", formerly NYSE: GIX), a PPE company. On June 9 2021 GIG2 was renamed UpHealth, Inc. and continues to be listed on the NYSE under the new ticker symbol "UPH" following GIG2’s business combinations with UpHealth Holdings, Inc. and Cloudbreak Health, LLC. He is the Executive Chairman of the Board of UpHealth, Inc. (NYSE: UPH) since inception of the company as GIG2 and was the Chief Executive Officer of GIG2 from March 2019 until August 2019. In February 2020 Dr. Katz co-founded GigCapital3 Inc. ("GIG3", formerly NYSE: GIK) PPE company. On May 6 2021 GIG3 was renamed Lightning eMotors, Inc. and continues to be listed on the NYSE under the new ticker symbol "ZEV." From the inception of GIG3 until the closing of its business combination in May 2021 Dr. Katz served as the Chief Executive Officer, Executive Chairman and Secretary of GIG3. Following the business combination, Dr. Katz serves as the Co-Chairman of the Board of Directors of Lightning eMotors, Inc (NYSE ZEV). He is also the Founder of four other Private-to-Public Equity (PPE) companies, three of which he is also Executive Chairman - GigCapital4 Inc. ("GIG4", NASDAQ: GIG), GigCapital5 Inc. ("GIG5") and GigInternational1 Inc. ("GIGINTL1", NASDAQ: GIW) since their inceptions in December 2020 February 2021 and February 2021 respectively - and one of which he is also a member of the board of directors - GigCapital6 Inc. ("GIG6") since February 2021. GIG4 and GIGINTL1 have already conducted their initial public offerings in February 2021 and May 2021 respectively, and in June 2021 GIG4 has announced a proposed business combination with BigBear.ai Holdings, LLC. GIG5 and GIG6 have each filed registration statements with the SEC for their initial public offerings. Dr. Katz is also the sole founding managing member of GigFounders, LLC and a founding managing member of GigManagement, LLC. Dr. Katz is also the co-founder and from its inception in December 2018 until August 2020 served as the Executive Chairman of the Board of Cognizer, Inc., an artificial intelligence ("AI") company with a natural language understanding platform based on deep learning formed in December 2018. Previously, Dr. Katz dedicated 10 years to developing and managing GigPeak (NYSE American: formerly GIG), originally known as GigOptix, Inc. since he incepted it in April 2007 until its sale in April 2017 GigPeak provided semiconductor integrated circuits (ICs) and software solutions for high-speed connectivity and video compression. While Dr. Katz was at GigPeak’s helm, the company completed 10 M&A deals. GigPeak was sold to Integrated Device Technology, Inc. (Nasdaq: IDTI) for $250 million in cash in April 2017. From 2003 to 2005 Dr. Katz was the chief executive officer, president, and member of the Board of Directors of Intransa, Inc., which at the time provided full-featured, enterprise-class IP-based Storage Area Networks (SAN). From 2000 to 2003 Dr. Katz was the Chief Executive Officer of Equator Technologies. Equator Technologies sought to commercialize leading edge programmable media processing platform technology for the rapid design and deployment of digital media and imaging products. Equator Technologies was sold to Pixelworks, Inc. for $110 million in 2005. Dr. Katz has held several leadership positions over the span of his 34-year career within the technology industry and has made numerous angel investments in high-tech companies around the world. In addition, Dr. Katz is a graduate of the Israeli Naval Academy and holds a B.Sc. and Ph.D. in Semiconductors Materials from the Technion (Israel Institute of Technology). He is a global philanthropist, serial entrepreneur and long-time angel investor in the TMT sector, holds many U.S. and international patents, has published many technical papers and is the editor of a number of technical books. - AviS.Katz自2019年3月起担任我们的董事会执行主席，从那时起至2019年8月，他还担任我们的首席执行官，总裁兼秘书。自2020年2月起，他还担任GigCapital3Inc.的董事会执行主席，首席执行官，总裁兼秘书。他也是GigFounders，LLC的创始管理成员，以及我们赞助商的经理，以及GigAcquisitions，LLC GigCapital and GigAcquisitions3LLC（GigCapital3Inc.的赞助商）的赞助商。Katz博士在TMT行业担任了近32年的国际执行职位，为私人持有的初创企业，中型公司和大型企业工作。在担任这些职务期间，卡茨博士在建立和加速实体、建立团队、大规模筹资、发展关键联盟和技术伙伴关系、并购活动、企业发展、财务管理、全球业务和销售与市场营销等方面发挥了重要作用。2017年10月，Katz博士创立了GigCapital，这是一家为收购科技行业公司而成立的私募股权（PPE）公司。GigCapital于2017年12月完成了首次公开募股，其中以每单位10.00美元的价格出售了14375000股，每单位由一股GigCapital普通股组成，购买一股GigCapital普通股的认股权证的四分之三（3/4）和获得一股GigCapital普通股的十分之一（1/10）的权利，产生的总收益为143750000美元，当时在纽约证券交易所上市，股票代码为“；GIG。在对全球400多家公司进行了密集筛选后，GigCapital于2019年2月22日签订了一项股票购买协议，以交易企业价值1.87亿美元的价格收购Kaleyra S.p.A.，合并现金和/或本票对价为1500万美元。Kaleyra S.p.A.是一家全球性公司，专门为金融机构和各种规模的公司提供移动消息服务。交易于2019年11月25日完成，GigCapital更名为Kaleyra，Inc.，并在当时的纽约证券交易所美国证券交易所上市，股票代码为“；KLR”；。自2019年11月交易完成以来，Katz博士一直担任Kaleyra，Inc.的执行主席。他也是GigCapital3Inc.的创始人，董事会执行主席兼首席执行官，自2020年2月在特拉华州注册成立以来。Katz博士还是Cognizer，Inc.（人工智能（“；AI”；）公司的联合创始人，并从2018年12月成立至2020年8月担任其董事会执行主席，该公司拥有基于深度学习的自然语言理解平台。此前，Katz博士致力于开发和管理Gigpeak（NYSE American:前身为GIG），原名为Gigoptix，Inc.，历时10年。从2007年4月成立到2017年4月出售，Gigpeak为高速连接和视频压缩提供半导体集成电路（IC）和软件解决方案。在Katz博士掌舵Gigpeak&8217；期间，该公司完成了10笔并购交易。Gigpeak于2017年4月以2.5亿美元的现金出售给Integrated DeviceTechnology，Inc.（NASDAQ:IDTI）。从2003年到2005年，Katz博士担任Intransa，Inc.的首席执行官，总裁兼董事会成员，该公司当时提供全功能，基于企业级IP的存储区域网（SAN）。从2000年到2003年，Katz博士担任Equator Technologies的首席执行官。Equator Technologies寻求将领先的可编程媒体处理平台技术商业化，以快速设计和部署数字媒体和成像产品。Equator Technologies于2005年以1.1亿美元的价格出售给Pixelworks，Inc.。Katz博士在其30多年的科技行业职业生涯中担任过多个领导职位，并对世界各地的高科技公司进行过众多天使投资。此外，Katz博士是以色列海军学院（Israeli Naval Academy）的毕业生，并持有学士学位。以及the Technion（以色列理工学院）半导体材料博士学位。他是TMT领域的连续企业家和长期天使投资人，持有70多项美国和国际专利，发表了大约300篇技术论文，是多本技术书籍的编辑。
- Avi S. Katz erved as GigCapital, Inc. formerly NYSE: GIG Founder, Executive Chairman of the Board, Chief Executive Officer, President and Secretary since October 2017 and upon the closing of the Business Combination, when GigCapital, Inc. renamed itself Kaleyra, Inc., Dr. Katz transitioned to be the Executive Chairman of our Board of Directors of Kaleyra, Inc. (NYSE: KLR). Dr. Katz has spent approximately 34 years in international executive positions within the technology, media and telecommunications (TMT) industry working for privately held start-ups, middle-cap companies and large enterprises. In these roles, Dr. Katz has been instrumental in launching and accelerating entities, building teams, large scale fund-raising, developing key alliances and technology partnerships, domestic and international M&A activities, business development, financial management, global operations and sales and marketing. Dr. Katz is the Founder and Sole Founding Manager of GigCapital Global (GigCG), which he incepted in 2017 and its affiliated entities, including GigAcquisitions, LLC, GigAcquisitions2 LLC, GigAcquisitions3 LLC, GigAcquisitions4 LLC, GigAcquisitions5 LLC, GigAcquisitions6 LLC and GigInternational1 Sponsor, LLC, all of which are sponsors to Private-to-Public Equity (PPE) companies which have been formed for the purpose of acquiring companies in the technology industry. GigCG is an inceptor and managing group of Private-to-Public Equity (PPE) entities, also known as a blank check company or special purpose acquisition company (SPAC) vehicles. Following the inception of GigCapital, inc., in March 2019 Dr. Katz founded GigCapital2 Inc. ("GIG2", formerly NYSE: GIX), a PPE company. On June 9 2021 GIG2 was renamed UpHealth, Inc. and continues to be listed on the NYSE under the new ticker symbol "UPH" following GIG2’s business combinations with UpHealth Holdings, Inc. and Cloudbreak Health, LLC. He is the Executive Chairman of the Board of UpHealth, Inc. (NYSE: UPH) since inception of the company as GIG2 and was the Chief Executive Officer of GIG2 from March 2019 until August 2019. In February 2020 Dr. Katz co-founded GigCapital3 Inc. ("GIG3", formerly NYSE: GIK) PPE company. On May 6 2021 GIG3 was renamed Lightning eMotors, Inc. and continues to be listed on the NYSE under the new ticker symbol "ZEV." From the inception of GIG3 until the closing of its business combination in May 2021 Dr. Katz served as the Chief Executive Officer, Executive Chairman and Secretary of GIG3. Following the business combination, Dr. Katz serves as the Co-Chairman of the Board of Directors of Lightning eMotors, Inc (NYSE ZEV). He is also the Founder of four other Private-to-Public Equity (PPE) companies, three of which he is also Executive Chairman - GigCapital4 Inc. ("GIG4", NASDAQ: GIG), GigCapital5 Inc. ("GIG5") and GigInternational1 Inc. ("GIGINTL1", NASDAQ: GIW) since their inceptions in December 2020 February 2021 and February 2021 respectively - and one of which he is also a member of the board of directors - GigCapital6 Inc. ("GIG6") since February 2021. GIG4 and GIGINTL1 have already conducted their initial public offerings in February 2021 and May 2021 respectively, and in June 2021 GIG4 has announced a proposed business combination with BigBear.ai Holdings, LLC. GIG5 and GIG6 have each filed registration statements with the SEC for their initial public offerings. Dr. Katz is also the sole founding managing member of GigFounders, LLC and a founding managing member of GigManagement, LLC. Dr. Katz is also the co-founder and from its inception in December 2018 until August 2020 served as the Executive Chairman of the Board of Cognizer, Inc., an artificial intelligence ("AI") company with a natural language understanding platform based on deep learning formed in December 2018. Previously, Dr. Katz dedicated 10 years to developing and managing GigPeak (NYSE American: formerly GIG), originally known as GigOptix, Inc. since he incepted it in April 2007 until its sale in April 2017 GigPeak provided semiconductor integrated circuits (ICs) and software solutions for high-speed connectivity and video compression. While Dr. Katz was at GigPeak’s helm, the company completed 10 M&A deals. GigPeak was sold to Integrated Device Technology, Inc. (Nasdaq: IDTI) for $250 million in cash in April 2017. From 2003 to 2005 Dr. Katz was the chief executive officer, president, and member of the Board of Directors of Intransa, Inc., which at the time provided full-featured, enterprise-class IP-based Storage Area Networks (SAN). From 2000 to 2003 Dr. Katz was the Chief Executive Officer of Equator Technologies. Equator Technologies sought to commercialize leading edge programmable media processing platform technology for the rapid design and deployment of digital media and imaging products. Equator Technologies was sold to Pixelworks, Inc. for $110 million in 2005. Dr. Katz has held several leadership positions over the span of his 34-year career within the technology industry and has made numerous angel investments in high-tech companies around the world. In addition, Dr. Katz is a graduate of the Israeli Naval Academy and holds a B.Sc. and Ph.D. in Semiconductors Materials from the Technion (Israel Institute of Technology). He is a global philanthropist, serial entrepreneur and long-time angel investor in the TMT sector, holds many U.S. and international patents, has published many technical papers and is the editor of a number of technical books.
- Agnes Rey Giraud
-
Agnes Rey Giraud于2021年6月完成业务合并后加入Uphealth，Inc.董事会。Rey-Giraud女士是Acera Surgical，Inc.的董事长，她于2013年与他人共同创立了Acera Surgical，Inc.，并在2022年5月之前担任该公司的首席执行官。Acera Surgical公司设计了一种新型的可吸收合成混合尺度纤维基质，旨在修复受损组织。Rey-Giraud女士之前是Express Scripts控股公司Nasdaq：ESRX的一名高级职员，该公司是一家财富100强公司，在该公司担任多个行政职务，包括产品开发、供应链、公司战略执行副总裁和国际运营总裁，职责日益增加。Rey-Giraud女士目前担任GoodRx，Inc.（纳斯达克股票代码：GDRX）的董事会成员，自2016年起担任该职务。该公司最近完成了一项价值数十亿美元的IPO IPO。GoodRx提供一系列服务，帮助人们以负担得起的价格获得所需的医疗保健。此外，Rey-Giraud女士还曾在多个董事会任职，包括从2000年到2006年设计和创立的医疗保健技术服务公司RxHub（现为SureScripts）。在此期间，RxHub从一个商业计划转变为一个服务和技术平台，促进了通信标准的制定和电子处方在美国的采用，而电子处方现在已成为该国的共同标准。她的其他董事会职务包括2011年9月至2020年6月的健康公司Pritikin和2013年9月至2015年3月的私人药品批发经销商HD Smith。Rey-Giraud女士是一名癌症幸存者，她将挽救生命的治疗归功于一项临床试验。此后，她一直倡导提高对乳腺癌的认识和负担得起的医疗保健，特别是对诊断为衰弱或绝症的患者。Rey-Giraud女士拥有芝加哥大学工商管理硕士学位、里昂商学院运营管理硕士学位以及同样在法国获得的工程学硕士学位。她曾获得西北大学和哈佛学院的董事会服务证书。
Agnes Rey Giraud joined Uphealth, Inc.'s Board upon the closing of the Business Combinations in June 2021. Ms. Rey-Giraud is Chairman of Acera Surgical, Inc., which she co-founded in 2013 and until May 2022 was its Chief Executive Officer. Acera Surgical has engineered a new class of resorbable synthetic hybrid-scale fiber matrices designed to restore damaged tissue. Ms. Rey-Giraud was previously an officer at Express Scripts Holding Company Nasdaq: ESRX, a Fortune 100 company, where she served in multiple executive roles of increasing responsibility, including Executive Vice President of Product Development, Supply Chain, Corporate Strategy and President of International Operations. Ms. Rey-Giraud currently serves on the board of GoodRx, Inc. (Nasdaq: GDRX), a role she has held since 2016. The company recently completed a multibillion IPO. GoodRx offers a range of services that help people get the healthcare they need at a price they can afford. In addition, Ms. Rey-Giraud has served on numerous boards of directors, including RxHub (now SureScripts), a healthcare technology services company, from its design and creation from 2000 to 2006. During this period, RxHub transformed from a business plan to a service and technology platform, facilitating the creation of communication standards and the adoption of electronic prescribing in the United States that are now the common standard in the country. Her other board roles have included Pritikin, a wellness company, from September 2011 to June 2020 and HD Smith, a privately owned drug wholesale distributor, from September 2013 to March 2015. Ms. Rey-Giraud is a cancer survivor who credits a clinical trial with her life-saving treatment. She has since become an advocate for breast cancer awareness and affordable health care, especially for patients diagnosed with debilitating or terminal illness. Ms. Rey-Giraud holds an MBA from the University of Chicago, a Master of Management in Operations from Ecole de Management de Lyon Business School, and a Master's Degree in engineering, also earned in France. She has earned certifications in board service from Northwestern University and Harvard College. - Agnes Rey Giraud于2021年6月完成业务合并后加入Uphealth，Inc.董事会。Rey-Giraud女士是Acera Surgical，Inc.的董事长，她于2013年与他人共同创立了Acera Surgical，Inc.，并在2022年5月之前担任该公司的首席执行官。Acera Surgical公司设计了一种新型的可吸收合成混合尺度纤维基质，旨在修复受损组织。Rey-Giraud女士之前是Express Scripts控股公司Nasdaq：ESRX的一名高级职员，该公司是一家财富100强公司，在该公司担任多个行政职务，包括产品开发、供应链、公司战略执行副总裁和国际运营总裁，职责日益增加。Rey-Giraud女士目前担任GoodRx，Inc.（纳斯达克股票代码：GDRX）的董事会成员，自2016年起担任该职务。该公司最近完成了一项价值数十亿美元的IPO IPO。GoodRx提供一系列服务，帮助人们以负担得起的价格获得所需的医疗保健。此外，Rey-Giraud女士还曾在多个董事会任职，包括从2000年到2006年设计和创立的医疗保健技术服务公司RxHub（现为SureScripts）。在此期间，RxHub从一个商业计划转变为一个服务和技术平台，促进了通信标准的制定和电子处方在美国的采用，而电子处方现在已成为该国的共同标准。她的其他董事会职务包括2011年9月至2020年6月的健康公司Pritikin和2013年9月至2015年3月的私人药品批发经销商HD Smith。Rey-Giraud女士是一名癌症幸存者，她将挽救生命的治疗归功于一项临床试验。此后，她一直倡导提高对乳腺癌的认识和负担得起的医疗保健，特别是对诊断为衰弱或绝症的患者。Rey-Giraud女士拥有芝加哥大学工商管理硕士学位、里昂商学院运营管理硕士学位以及同样在法国获得的工程学硕士学位。她曾获得西北大学和哈佛学院的董事会服务证书。
- Agnes Rey Giraud joined Uphealth, Inc.'s Board upon the closing of the Business Combinations in June 2021. Ms. Rey-Giraud is Chairman of Acera Surgical, Inc., which she co-founded in 2013 and until May 2022 was its Chief Executive Officer. Acera Surgical has engineered a new class of resorbable synthetic hybrid-scale fiber matrices designed to restore damaged tissue. Ms. Rey-Giraud was previously an officer at Express Scripts Holding Company Nasdaq: ESRX, a Fortune 100 company, where she served in multiple executive roles of increasing responsibility, including Executive Vice President of Product Development, Supply Chain, Corporate Strategy and President of International Operations. Ms. Rey-Giraud currently serves on the board of GoodRx, Inc. (Nasdaq: GDRX), a role she has held since 2016. The company recently completed a multibillion IPO. GoodRx offers a range of services that help people get the healthcare they need at a price they can afford. In addition, Ms. Rey-Giraud has served on numerous boards of directors, including RxHub (now SureScripts), a healthcare technology services company, from its design and creation from 2000 to 2006. During this period, RxHub transformed from a business plan to a service and technology platform, facilitating the creation of communication standards and the adoption of electronic prescribing in the United States that are now the common standard in the country. Her other board roles have included Pritikin, a wellness company, from September 2011 to June 2020 and HD Smith, a privately owned drug wholesale distributor, from September 2013 to March 2015. Ms. Rey-Giraud is a cancer survivor who credits a clinical trial with her life-saving treatment. She has since become an advocate for breast cancer awareness and affordable health care, especially for patients diagnosed with debilitating or terminal illness. Ms. Rey-Giraud holds an MBA from the University of Chicago, a Master of Management in Operations from Ecole de Management de Lyon Business School, and a Master's Degree in engineering, also earned in France. She has earned certifications in board service from Northwestern University and Harvard College.
- Samuel J. Meckey
-
Samuel J. Meckey于2022年7月加入Uphealth，Inc.的董事会，并担任Uphealth，Inc.的首席执行官。在加入UpHealth之前，他于2018年11月起担任EXLService Holdings，Inc.（一家领先的数据分析、数字运营、技术和解决方案公司）的执行副总裁，并于2019年起担任医疗保健业务主管。在他任职期间，他将五个独立的业务整合为一个有凝聚力的运营单位，并制定了将业务规模扩大一倍的战略计划，增加了收入和净收入，提高了毛利率，并显着提高了投资资本回报率。在加入EXLService Holdings，Inc.之前，Meckey先生曾担任联合健康集团Optum全球解决方案总裁，负责该公司的全球运营和技术服务组织，并负责印度、菲律宾、巴西和美国的35000多名员工，在此之前，2004年5月至2018年6月，他在联合健康集团担任过多个行政职务。在加入联合健康集团之前，梅基先生曾于1992年5月至2002年8月在美国海军担任军官和海军飞行员。他在美国海军学院获得经济学学士学位，在哈佛商学院获得工商管理硕士学位。
Samuel J. Meckey joined Uphealth, Inc.'s Board in July 2022 and also serves as Uphealth, Inc.'s Chief Executive Officer. Prior to joining UpHealth, he served as the Executive Vice President of EXLService Holdings, Inc., a leading data analytics, digital operations, technology and solutions company, since November 2018 and as its Business Head, Healthcare beginning in 2019. During his tenure, he integrated five separate businesses into one cohesive operating unit and developed the strategic plan to double the business's size, grew revenues and net income, increased gross margin and significantly improved return on invested capital. Prior to joining EXLService Holdings, Inc., Mr. Meckey served as President of UnitedHealth Group's Optum Global Solutions, where he oversaw the company's global operations and technology services organization and was responsible for more than 35000 employees in India, the Philippines, Brazil and the United States, and before that, he held various executive roles at UnitedHealth Group, where he was employed from May 2004 to June 2018. Prior to joining UnitedHealth Group, Mr. Meckey was an officer and naval aviator in the United States Navy from May 1992 to August 2002. He earned a B.S. in Economics from the United States Naval Academy and an MBA from Harvard Business School. - Samuel J. Meckey于2022年7月加入Uphealth，Inc.的董事会，并担任Uphealth，Inc.的首席执行官。在加入UpHealth之前，他于2018年11月起担任EXLService Holdings，Inc.（一家领先的数据分析、数字运营、技术和解决方案公司）的执行副总裁，并于2019年起担任医疗保健业务主管。在他任职期间，他将五个独立的业务整合为一个有凝聚力的运营单位，并制定了将业务规模扩大一倍的战略计划，增加了收入和净收入，提高了毛利率，并显着提高了投资资本回报率。在加入EXLService Holdings，Inc.之前，Meckey先生曾担任联合健康集团Optum全球解决方案总裁，负责该公司的全球运营和技术服务组织，并负责印度、菲律宾、巴西和美国的35000多名员工，在此之前，2004年5月至2018年6月，他在联合健康集团担任过多个行政职务。在加入联合健康集团之前，梅基先生曾于1992年5月至2002年8月在美国海军担任军官和海军飞行员。他在美国海军学院获得经济学学士学位，在哈佛商学院获得工商管理硕士学位。
- Samuel J. Meckey joined Uphealth, Inc.'s Board in July 2022 and also serves as Uphealth, Inc.'s Chief Executive Officer. Prior to joining UpHealth, he served as the Executive Vice President of EXLService Holdings, Inc., a leading data analytics, digital operations, technology and solutions company, since November 2018 and as its Business Head, Healthcare beginning in 2019. During his tenure, he integrated five separate businesses into one cohesive operating unit and developed the strategic plan to double the business's size, grew revenues and net income, increased gross margin and significantly improved return on invested capital. Prior to joining EXLService Holdings, Inc., Mr. Meckey served as President of UnitedHealth Group's Optum Global Solutions, where he oversaw the company's global operations and technology services organization and was responsible for more than 35000 employees in India, the Philippines, Brazil and the United States, and before that, he held various executive roles at UnitedHealth Group, where he was employed from May 2004 to June 2018. Prior to joining UnitedHealth Group, Mr. Meckey was an officer and naval aviator in the United States Navy from May 1992 to August 2002. He earned a B.S. in Economics from the United States Naval Academy and an MBA from Harvard Business School.
- Nathan Locke
-
Nathan Locke于2021年6月完成业务合并后加入了Uphealth，Inc.的董事会。Locke先生是Kayne Anderson Capital Advisors增长股票业务的执行合伙人和联席主管。他在Kayne Anderson工作了十几年，寻找和分析技术和科技型服务公司的投资机会，并在董事会层面协助这些公司扩大投资后的规模。他曾在医疗保健技术和远程医疗、媒体和电信、安全和合规以及供应链和物流等处于不同成长阶段的公司任职。在2008年加入凯恩·安德森之前，骆家辉曾在罗姆尼总裁公司的财务团队担任高级分析师，并担任英联邦政治行动委员会的财务总监。骆家辉在犹他大学获得金融学学士学位，并以优异的成绩从戴维·埃克尔斯商学院毕业。
Nathan Locke joined Uphealth, Inc.'s Board upon the closing of the Business Combinations in June 2021. Mr. Locke is a Managing Partner and Co-Head of Kayne Anderson Capital Advisors' growth equity activities. He has spent more than a dozen years at Kayne Anderson identifying and analyzing investment opportunities in technology and tech-enabled service companies, and assisting at the board level in helping those companies as they scale post-investment. He has been involved with companies at various stages of growth in healthcare technology and telemedicine, media & telecom, security & compliance and supply chain & logistics. Prior to joining Kayne Anderson in 2008 Mr. Locke worked as a senior analyst on the finance team of Romney for President, Inc., and as the controller for The Commonwealth Political Action Committees. Mr. Locke earned a B.S. in Finance from the University of Utah, where he graduated magna cum laude from the David Eccles School of Business. - Nathan Locke于2021年6月完成业务合并后加入了Uphealth，Inc.的董事会。Locke先生是Kayne Anderson Capital Advisors增长股票业务的执行合伙人和联席主管。他在Kayne Anderson工作了十几年，寻找和分析技术和科技型服务公司的投资机会，并在董事会层面协助这些公司扩大投资后的规模。他曾在医疗保健技术和远程医疗、媒体和电信、安全和合规以及供应链和物流等处于不同成长阶段的公司任职。在2008年加入凯恩·安德森之前，骆家辉曾在罗姆尼总裁公司的财务团队担任高级分析师，并担任英联邦政治行动委员会的财务总监。骆家辉在犹他大学获得金融学学士学位，并以优异的成绩从戴维·埃克尔斯商学院毕业。
- Nathan Locke joined Uphealth, Inc.'s Board upon the closing of the Business Combinations in June 2021. Mr. Locke is a Managing Partner and Co-Head of Kayne Anderson Capital Advisors' growth equity activities. He has spent more than a dozen years at Kayne Anderson identifying and analyzing investment opportunities in technology and tech-enabled service companies, and assisting at the board level in helping those companies as they scale post-investment. He has been involved with companies at various stages of growth in healthcare technology and telemedicine, media & telecom, security & compliance and supply chain & logistics. Prior to joining Kayne Anderson in 2008 Mr. Locke worked as a senior analyst on the finance team of Romney for President, Inc., and as the controller for The Commonwealth Political Action Committees. Mr. Locke earned a B.S. in Finance from the University of Utah, where he graduated magna cum laude from the David Eccles School of Business.
- Mariya Pylypiv
-
Mariya Pylypiv自2021年6月业务合并完成后一直担任Uphealth，Inc.董事会成员，此前曾于2022年4月至2022年9月担任UpHealth公司财务高级副总裁。她是UpHealth的联合创始人，此前曾担任UpHealth副董事长兼董事会秘书。在此之前，她在UpHealth服务公司2019年11月成立后担任同样的职务。从2018年1月开始，Pylypiv博士负责UpHealth服务公司的业务和公司战略的制定，该公司于2019年11月成立。Pylypiv博士于2018年3月至2021年7月在Sikich LLC工作。在此之前，她于2016年2月至2018年3月在Acrospire Investment Management LLC负责全球绝对回报多头/空头市场中性股票策略的运营、交易和开发，最近担任投资银行和企业发展副总裁副总裁。Pylypiv博士于2014年7月至2016年1月担任Rotella资本管理公司的量化研究分析师，负责制定研究战略并监督基金运作和交易活动。Pylypiv博士还曾在投资银行、金融投资、健康科技和技术领域的公司担任顾问委员会成员。Pylypiv博士拥有Precarpathian国立大学会计学学士和硕士学位、捷尔诺波尔国立经济大学国际经济和旅游硕士学位和普渡大学博士学位。
Mariya Pylypiv has served as Chief Financial Officer since May 2024 and, prior to that, as interim Chief Financial Officer from June 2023 to May 2024. She also served as Director and President of Maven Execs, a CFO services firm she co founded, from September 2022 to May 2024. In addition, she currently serves as a director for UpHealth, Inc. (OTC: UPH), a digital health company, where she previoly held several executive positions, including Vice President of Finance from May 2022 to Augt 2022 and Chief Strategy Officer from June 2021 to May 2022. Prior to that, she served as Vice President of Investment Banking and Corporate Development at Sikich LLP, a professional services firm specializing in accounting, technology, investment banking and advisory services, from January 2021 to Augt 2021 and as an Investment Banking and Corporate Development Associate from March 2018 to December 2020. Her early career includes roles as Senior Research Analyst at Acrospire Investment Management LLC, from February 2016 to March 2018, and Quantitative Research Analyst at Rotella Capital Management from, July 2014 to January 2016. She holds a Bachelor of Biness Economics in Accounting and Audit and a Master's in Accounting and Audit from Vasyl Stefanyk Precarpathian National University, as ll as B.A. and M.A. degrees in International Economics from Ternopil National Economic University. Additionally, she earned her Ph.D. in Consumer and Family Economics with a foc on Finance from Purdue University. She has also completed multiple certifications in financial accounting, ESG, corporate governance, and cybersecurity. - Mariya Pylypiv自2021年6月业务合并完成后一直担任Uphealth，Inc.董事会成员，此前曾于2022年4月至2022年9月担任UpHealth公司财务高级副总裁。她是UpHealth的联合创始人，此前曾担任UpHealth副董事长兼董事会秘书。在此之前，她在UpHealth服务公司2019年11月成立后担任同样的职务。从2018年1月开始，Pylypiv博士负责UpHealth服务公司的业务和公司战略的制定，该公司于2019年11月成立。Pylypiv博士于2018年3月至2021年7月在Sikich LLC工作。在此之前，她于2016年2月至2018年3月在Acrospire Investment Management LLC负责全球绝对回报多头/空头市场中性股票策略的运营、交易和开发，最近担任投资银行和企业发展副总裁副总裁。Pylypiv博士于2014年7月至2016年1月担任Rotella资本管理公司的量化研究分析师，负责制定研究战略并监督基金运作和交易活动。Pylypiv博士还曾在投资银行、金融投资、健康科技和技术领域的公司担任顾问委员会成员。Pylypiv博士拥有Precarpathian国立大学会计学学士和硕士学位、捷尔诺波尔国立经济大学国际经济和旅游硕士学位和普渡大学博士学位。
- Mariya Pylypiv has served as Chief Financial Officer since May 2024 and, prior to that, as interim Chief Financial Officer from June 2023 to May 2024. She also served as Director and President of Maven Execs, a CFO services firm she co founded, from September 2022 to May 2024. In addition, she currently serves as a director for UpHealth, Inc. (OTC: UPH), a digital health company, where she previoly held several executive positions, including Vice President of Finance from May 2022 to Augt 2022 and Chief Strategy Officer from June 2021 to May 2022. Prior to that, she served as Vice President of Investment Banking and Corporate Development at Sikich LLP, a professional services firm specializing in accounting, technology, investment banking and advisory services, from January 2021 to Augt 2021 and as an Investment Banking and Corporate Development Associate from March 2018 to December 2020. Her early career includes roles as Senior Research Analyst at Acrospire Investment Management LLC, from February 2016 to March 2018, and Quantitative Research Analyst at Rotella Capital Management from, July 2014 to January 2016. She holds a Bachelor of Biness Economics in Accounting and Audit and a Master's in Accounting and Audit from Vasyl Stefanyk Precarpathian National University, as ll as B.A. and M.A. degrees in International Economics from Ternopil National Economic University. Additionally, she earned her Ph.D. in Consumer and Family Economics with a foc on Finance from Purdue University. She has also completed multiple certifications in financial accounting, ESG, corporate governance, and cybersecurity.
- Chirinjeev Kathuria
-
自2021年6月业务合并结束以来，Chirinjeev Kathuria一直担任Uphealth，Inc.董事会成员，此前还担任Uphealth，Inc.董事会联席主席至2022年6月。Kathuria博士是一位印度裔美国投资者、商人和慈善家。在2019年11月重组UpHealth服务公司后，他于2020年10月与他人共同创立了UpHealth控股公司。在业务合并完成之前，他曾担任UpHealth控股公司和UpHealth服务公司的董事会主席。Kathuria博士于2019年1月与他人共同创立了Ocean Biomedical，并自成立以来一直担任该公司的董事会主席。Ocean Biomedical是一家生物技术公司，与领先的科学家和研究机构合作，以加速将新发现转化为突破性药物。Kathuria博士还于2020年3月与他人共同创立了AIRO集团，并担任该集团董事会主席，自成立以来一直担任这一职务。AIRO集团为国防和商业市场的下一代航空电子设备、有人驾驶和无人驾驶以及多模式运输提供端到端解决方案。此外，Kathuria博士于2009年2月与他人共同创立并担任New Generation Power的董事长，并于2003年3月创立并担任American Teleradiology NightHawks，Inc.的董事。美国Teleradiology NightHawks，Inc.与NightHawk Radiology Holdings，Inc.合并，合并后的公司于2006年10月在纳斯达克上市。Kathuria博士于1998年3月至2000年3月担任X-Stream网络公司的董事，该公司是一家互联网服务提供商，后来被出售给Liberty Surf Group S.A.，随后在巴黎证券交易所上市。Kathuria博士还参与了空间探索，并于1999年1月成为MirCorp的创始董事，这是第一家私人发射和资助载人航天计划的商业公司。Kathuria博士在伊利诺伊州竞选美国联邦参议员，成为美国历史上第一位竞选美国联邦参议员的印裔美国人，其中包括最终的获胜者奥巴马总统。Kathuria博士在布朗大学获得理学学士学位和医学博士学位，在斯坦福大学获得工商管理硕士学位。
Chirinjeev Kathuria has served Executive Chairman since inception in 2020. Dr. Kathuria is an Indian American investor, binessperson, and philanthropist. He is co founder and serves on the board of directors of UpHealth, Inc. (OTC: UPH), a digital health company founded in 2020. Dr. Kathuria also co founded Ocean Biomedical, Inc. (Nasdaq: OCEA), a biopharmaceutical company, and serves as the executive chairman of its board of directors, a position he has held since its inception in 2019. In addition, Dr. Kathuria co founded New Generation Por, an energy company, in February 2009 and American Teleradiology NightHawks, Inc., a telemedicine company, in March 2003. American Teleradiology NightHawks, Inc. merged with NightHawk Radiology Holdings, Inc. and the combined company nt public on Nasdaq in October 2006. From March 1998 to March 2000, Dr. Kathuria served as a director of The X Stream Networks Inc., an internet service provider, that was sold to Liberty Surf Group S.A. and subsequently nt public on the Paris Stock Exchange. Dr. Kathuria has also been involved in space exploration and, in January 1999, became the founding director of MirCorp, the first commercial company to privately launch and fund manned space programs. Dr. Kathuria received a Bachelor of Science and Doctor of Medicine from Brown University and a Master of Biness Administration from Stanford University. - 自2021年6月业务合并结束以来，Chirinjeev Kathuria一直担任Uphealth，Inc.董事会成员，此前还担任Uphealth，Inc.董事会联席主席至2022年6月。Kathuria博士是一位印度裔美国投资者、商人和慈善家。在2019年11月重组UpHealth服务公司后，他于2020年10月与他人共同创立了UpHealth控股公司。在业务合并完成之前，他曾担任UpHealth控股公司和UpHealth服务公司的董事会主席。Kathuria博士于2019年1月与他人共同创立了Ocean Biomedical，并自成立以来一直担任该公司的董事会主席。Ocean Biomedical是一家生物技术公司，与领先的科学家和研究机构合作，以加速将新发现转化为突破性药物。Kathuria博士还于2020年3月与他人共同创立了AIRO集团，并担任该集团董事会主席，自成立以来一直担任这一职务。AIRO集团为国防和商业市场的下一代航空电子设备、有人驾驶和无人驾驶以及多模式运输提供端到端解决方案。此外，Kathuria博士于2009年2月与他人共同创立并担任New Generation Power的董事长，并于2003年3月创立并担任American Teleradiology NightHawks，Inc.的董事。美国Teleradiology NightHawks，Inc.与NightHawk Radiology Holdings，Inc.合并，合并后的公司于2006年10月在纳斯达克上市。Kathuria博士于1998年3月至2000年3月担任X-Stream网络公司的董事，该公司是一家互联网服务提供商，后来被出售给Liberty Surf Group S.A.，随后在巴黎证券交易所上市。Kathuria博士还参与了空间探索，并于1999年1月成为MirCorp的创始董事，这是第一家私人发射和资助载人航天计划的商业公司。Kathuria博士在伊利诺伊州竞选美国联邦参议员，成为美国历史上第一位竞选美国联邦参议员的印裔美国人，其中包括最终的获胜者奥巴马总统。Kathuria博士在布朗大学获得理学学士学位和医学博士学位，在斯坦福大学获得工商管理硕士学位。
- Chirinjeev Kathuria has served Executive Chairman since inception in 2020. Dr. Kathuria is an Indian American investor, binessperson, and philanthropist. He is co founder and serves on the board of directors of UpHealth, Inc. (OTC: UPH), a digital health company founded in 2020. Dr. Kathuria also co founded Ocean Biomedical, Inc. (Nasdaq: OCEA), a biopharmaceutical company, and serves as the executive chairman of its board of directors, a position he has held since its inception in 2019. In addition, Dr. Kathuria co founded New Generation Por, an energy company, in February 2009 and American Teleradiology NightHawks, Inc., a telemedicine company, in March 2003. American Teleradiology NightHawks, Inc. merged with NightHawk Radiology Holdings, Inc. and the combined company nt public on Nasdaq in October 2006. From March 1998 to March 2000, Dr. Kathuria served as a director of The X Stream Networks Inc., an internet service provider, that was sold to Liberty Surf Group S.A. and subsequently nt public on the Paris Stock Exchange. Dr. Kathuria has also been involved in space exploration and, in January 1999, became the founding director of MirCorp, the first commercial company to privately launch and fund manned space programs. Dr. Kathuria received a Bachelor of Science and Doctor of Medicine from Brown University and a Master of Biness Administration from Stanford University.
- Avi S. Katz
-
Avi S. Katz与Raluca Dinu博士共同创立了公司，他也是GigCapital7的董事。Katz博士自2024年5月GigCapital7成立以来一直担任首席执行官和董事会主席。Katz博士持有赞助商50%的间接会员权益。Katz博士还持有赞助商的管理公司GigManagement，LLC 50%的会员权益，自该管理公司成立以来一直担任该管理公司的管理成员。Katz博士以这一身份指导了许多重组和再融资，包括在2021年6月以约2.25亿美元的现金加股票交易从黑石手中收购了mGAGE。在此之前，Katz博士曾担任GIG1的执行主席、秘书和首席执行官。2019年3月，Katz博士创立了GIG2，这是一家私募股权到公募股权（PPE）公司，成立的目的是收购TMT行业的一家公司。GIG2于2019年6月完成首次公开募股，其中以每单位10.00美元的价格出售了17，250，000个单位，每个单位包括一股GIG2普通股、一份购买一股GIG2普通股的认股权证，以及一份获得一股GIG2普通股的十分之一（1/20）的权利，产生的总收益约为1.73亿美元。2021年6月8日，GIG2完成了与UpHealth Holdings，Inc.和Cloudbreak Health，LLC各自的Biness合并，公司更名为UpHealth，Inc.并在纽约证券交易所上市，新股票代码为“UPH”，在该公司保持上市状态，直至2024年从纽约证券交易所退市并开始在OTC Pink交易，随后在OTC Expert Market上市，新股票代码为“UPHL”。Katz博士最初担任GIG2的首席执行官，直到2019年8月，Dinu博士接替他担任该职位。他是以色列海军学院1976届毕业生，1979 A海军ASW班毕业生，拥有Technion（以色列理工学院）材料学士和博士学位。
Avi S. Katz co founded Company together with Dr. Raluca Dinu, who is also a director of GigCapital7. Dr. Katz has served as the Chief Executive Officer and the Chairman of the Board since the inception of GigCapital7 in May 2024. Dr. Katz holds 50% indirect membership interest in the Sponsor. Dr. Katz also holds a 50% membership interest in GigManagement, LLC, the managing company of the Sponsor, and has served as a managing member of such managing company since its inception. In this capacity, Dr. Katz steered many restructurings and refinancings, including the acquisition of mGage from Blackstone for about $225 million in a cash and stock deal in June 2021. Prior to that time, Dr. Katz served as the Executive Chairman, Secretary, and Chief Executive Officer of GIG1. In March 2019, Dr. Katz founded GIG2, a Private to Public Equity (PPE) company formed for the purpose of acquiring a company in the TMT indtry. GIG2 completed its initial public offering in June 2019, in which it sold 17,250,000 units at a per unit price of $10.00, with each unit consisting of one share of GIG2 common stock, one warrant to purchase one share of GIG2 common stock, and one right to receive one tntieth (1/20) of one share of GIG2 common stock, generating aggregate proceeds of about $173 million. On June 8, 2021, GIG2 completed its biness combination with each of UpHealth Holdings, Inc. and Cloudbreak Health, LLC, and the company changed its name to UpHealth, Inc. and was listed on the NYSE under the new ticker symbol "UPH", where it remained listed until 2024 when it was delisted from the NYSE and commenced trading on the OTC Pink, and subsequently on the OTC Expert Market, under the new ticker symbol "UPHL." Dr. Katz initially served as the Chief Executive Officer of GIG2 until Augt 2019, when Dr. Dinu substituted for him in that position. He is a graduate of the 1976 class of the Israeli Naval Academy, graduate of the 1979 A Naval ASW class, and holds a B.Sc. and Ph.D. in Materials from the Technion (Israel Institute of Technology). - Avi S. Katz与Raluca Dinu博士共同创立了公司，他也是GigCapital7的董事。Katz博士自2024年5月GigCapital7成立以来一直担任首席执行官和董事会主席。Katz博士持有赞助商50%的间接会员权益。Katz博士还持有赞助商的管理公司GigManagement，LLC 50%的会员权益，自该管理公司成立以来一直担任该管理公司的管理成员。Katz博士以这一身份指导了许多重组和再融资，包括在2021年6月以约2.25亿美元的现金加股票交易从黑石手中收购了mGAGE。在此之前，Katz博士曾担任GIG1的执行主席、秘书和首席执行官。2019年3月，Katz博士创立了GIG2，这是一家私募股权到公募股权（PPE）公司，成立的目的是收购TMT行业的一家公司。GIG2于2019年6月完成首次公开募股，其中以每单位10.00美元的价格出售了17，250，000个单位，每个单位包括一股GIG2普通股、一份购买一股GIG2普通股的认股权证，以及一份获得一股GIG2普通股的十分之一（1/20）的权利，产生的总收益约为1.73亿美元。2021年6月8日，GIG2完成了与UpHealth Holdings，Inc.和Cloudbreak Health，LLC各自的Biness合并，公司更名为UpHealth，Inc.并在纽约证券交易所上市，新股票代码为“UPH”，在该公司保持上市状态，直至2024年从纽约证券交易所退市并开始在OTC Pink交易，随后在OTC Expert Market上市，新股票代码为“UPHL”。Katz博士最初担任GIG2的首席执行官，直到2019年8月，Dinu博士接替他担任该职位。他是以色列海军学院1976届毕业生，1979 A海军ASW班毕业生，拥有Technion（以色列理工学院）材料学士和博士学位。
- Avi S. Katz co founded Company together with Dr. Raluca Dinu, who is also a director of GigCapital7. Dr. Katz has served as the Chief Executive Officer and the Chairman of the Board since the inception of GigCapital7 in May 2024. Dr. Katz holds 50% indirect membership interest in the Sponsor. Dr. Katz also holds a 50% membership interest in GigManagement, LLC, the managing company of the Sponsor, and has served as a managing member of such managing company since its inception. In this capacity, Dr. Katz steered many restructurings and refinancings, including the acquisition of mGage from Blackstone for about $225 million in a cash and stock deal in June 2021. Prior to that time, Dr. Katz served as the Executive Chairman, Secretary, and Chief Executive Officer of GIG1. In March 2019, Dr. Katz founded GIG2, a Private to Public Equity (PPE) company formed for the purpose of acquiring a company in the TMT indtry. GIG2 completed its initial public offering in June 2019, in which it sold 17,250,000 units at a per unit price of $10.00, with each unit consisting of one share of GIG2 common stock, one warrant to purchase one share of GIG2 common stock, and one right to receive one tntieth (1/20) of one share of GIG2 common stock, generating aggregate proceeds of about $173 million. On June 8, 2021, GIG2 completed its biness combination with each of UpHealth Holdings, Inc. and Cloudbreak Health, LLC, and the company changed its name to UpHealth, Inc. and was listed on the NYSE under the new ticker symbol "UPH", where it remained listed until 2024 when it was delisted from the NYSE and commenced trading on the OTC Pink, and subsequently on the OTC Expert Market, under the new ticker symbol "UPHL." Dr. Katz initially served as the Chief Executive Officer of GIG2 until Augt 2019, when Dr. Dinu substituted for him in that position. He is a graduate of the 1976 class of the Israeli Naval Academy, graduate of the 1979 A Naval ASW class, and holds a B.Sc. and Ph.D. in Materials from the Technion (Israel Institute of Technology).
高管简历
中英对照 | 中文 | 英文- Samuel J. Meckey
Samuel J. Meckey于2022年7月加入Uphealth，Inc.的董事会，并担任Uphealth，Inc.的首席执行官。在加入UpHealth之前，他于2018年11月起担任EXLService Holdings，Inc.（一家领先的数据分析、数字运营、技术和解决方案公司）的执行副总裁，并于2019年起担任医疗保健业务主管。在他任职期间，他将五个独立的业务整合为一个有凝聚力的运营单位，并制定了将业务规模扩大一倍的战略计划，增加了收入和净收入，提高了毛利率，并显着提高了投资资本回报率。在加入EXLService Holdings，Inc.之前，Meckey先生曾担任联合健康集团Optum全球解决方案总裁，负责该公司的全球运营和技术服务组织，并负责印度、菲律宾、巴西和美国的35000多名员工，在此之前，2004年5月至2018年6月，他在联合健康集团担任过多个行政职务。在加入联合健康集团之前，梅基先生曾于1992年5月至2002年8月在美国海军担任军官和海军飞行员。他在美国海军学院获得经济学学士学位，在哈佛商学院获得工商管理硕士学位。
Samuel J. Meckey joined Uphealth, Inc.'s Board in July 2022 and also serves as Uphealth, Inc.'s Chief Executive Officer. Prior to joining UpHealth, he served as the Executive Vice President of EXLService Holdings, Inc., a leading data analytics, digital operations, technology and solutions company, since November 2018 and as its Business Head, Healthcare beginning in 2019. During his tenure, he integrated five separate businesses into one cohesive operating unit and developed the strategic plan to double the business's size, grew revenues and net income, increased gross margin and significantly improved return on invested capital. Prior to joining EXLService Holdings, Inc., Mr. Meckey served as President of UnitedHealth Group's Optum Global Solutions, where he oversaw the company's global operations and technology services organization and was responsible for more than 35000 employees in India, the Philippines, Brazil and the United States, and before that, he held various executive roles at UnitedHealth Group, where he was employed from May 2004 to June 2018. Prior to joining UnitedHealth Group, Mr. Meckey was an officer and naval aviator in the United States Navy from May 1992 to August 2002. He earned a B.S. in Economics from the United States Naval Academy and an MBA from Harvard Business School.- Samuel J. Meckey于2022年7月加入Uphealth，Inc.的董事会，并担任Uphealth，Inc.的首席执行官。在加入UpHealth之前，他于2018年11月起担任EXLService Holdings，Inc.（一家领先的数据分析、数字运营、技术和解决方案公司）的执行副总裁，并于2019年起担任医疗保健业务主管。在他任职期间，他将五个独立的业务整合为一个有凝聚力的运营单位，并制定了将业务规模扩大一倍的战略计划，增加了收入和净收入，提高了毛利率，并显着提高了投资资本回报率。在加入EXLService Holdings，Inc.之前，Meckey先生曾担任联合健康集团Optum全球解决方案总裁，负责该公司的全球运营和技术服务组织，并负责印度、菲律宾、巴西和美国的35000多名员工，在此之前，2004年5月至2018年6月，他在联合健康集团担任过多个行政职务。在加入联合健康集团之前，梅基先生曾于1992年5月至2002年8月在美国海军担任军官和海军飞行员。他在美国海军学院获得经济学学士学位，在哈佛商学院获得工商管理硕士学位。
- Samuel J. Meckey joined Uphealth, Inc.'s Board in July 2022 and also serves as Uphealth, Inc.'s Chief Executive Officer. Prior to joining UpHealth, he served as the Executive Vice President of EXLService Holdings, Inc., a leading data analytics, digital operations, technology and solutions company, since November 2018 and as its Business Head, Healthcare beginning in 2019. During his tenure, he integrated five separate businesses into one cohesive operating unit and developed the strategic plan to double the business's size, grew revenues and net income, increased gross margin and significantly improved return on invested capital. Prior to joining EXLService Holdings, Inc., Mr. Meckey served as President of UnitedHealth Group's Optum Global Solutions, where he oversaw the company's global operations and technology services organization and was responsible for more than 35000 employees in India, the Philippines, Brazil and the United States, and before that, he held various executive roles at UnitedHealth Group, where he was employed from May 2004 to June 2018. Prior to joining UnitedHealth Group, Mr. Meckey was an officer and naval aviator in the United States Navy from May 1992 to August 2002. He earned a B.S. in Economics from the United States Naval Academy and an MBA from Harvard Business School.
- Ramesh Balakrishnan
Ramesh Balakrishnan自2022年7月起担任Uphealth，Inc.总裁兼首席战略官。他之前曾担任Uphealth，Inc.的首席执行官，从业务合并结束到2022年7月，他转任现职。在此之前，Balakrishnan博士自2020年11月起担任UpHealth控股的联席首席执行官，直至合并完成，同时也是Thrasys公司的首席执行官。Thrasys是UpHealth控股的子公司，为综合护理管理提供技术平台和应用程序，从他于2002年3月成立该公司，直至业务合并结束。在创立Thrasys之前，Balakrishnan博士于1998年与他人共同创立了ePropose，Inc.，这是一家开创独特合作技术的技术公司。ePropose，Inc.于2001年与全球最大的私人控股公司Cargill，Inc.合并为一家合资企业。从1997年到1999年，Balakrishnan博士在Asyst Technologies担任软件部副总裁，负责软件部门的总体损益，并为全球半导体行业推出创新的解决方案。Asyst Technologies的客户代表了世界上一些最大的半导体制造厂，包括台湾半导体制造公司。在加入Asyst Technologies之前，Balakrishnan博士曾于1995年至1997年在Measurex公司担任应用总监，该公司提供用于离散和连续制造的关键任务实时控制系统。在Measurex公司，Balakrishnan博士以不同的角色开发和介绍了美国、欧洲、亚洲、日本和美洲市场领先的产品。Balakrishnan博士拥有斯坦福大学的博士和理学硕士学位，以及马德拉斯大学的工程学士学位。他还获得了印度政府为有前途的科学学者颁发的极具竞争力的国家科学人才奖学金。Balakrishnan博士在各个技术领域拥有14项国内和国际专利。
Ramesh Balakrishnan has served as Uphealth, Inc.'s President and Chief Strategy Officer since July 2022. He previously served as Uphealth, Inc.'s Chief Executive Officer from the closing of the Business Combinations until July 2022 when he transitioned to his current role. Prior to then, Dr. Balakrishnan served as Co-Chief Executive Officer of UpHealth Holdings from November 2020 until the closing of the Business Combinations, and was also the Chief Executive Officer of Thrasys, Inc. "Thrasys", a subsidiary of UpHealth Holdings that delivers technology platforms and applications for integrated care management, from its formation by him in March 2002 until the closing of the Business Combinations. Prior to founding Thrasys, Dr. Balakrishnan co-founded ePropose, Inc., a technology company that pioneered a unique technology for collaboration, in 1998. ePropose, Inc. was merged into a joint venture with Cargill, Inc. - the world's largest privately held company - in 2001. From 1997 to 1999 Dr. Balakrishnan was Vice President of Software at Asyst Technologies where he was responsible for overall profit and loss for the software division, and the launch of innovative solutions for the global semiconductor industry. Asyst Technologies' customers represented some of the largest semiconductor fabrication plants in the world including Taiwan Semiconductor Manufacturing Corporation. Prior to joining Asyst Technologies, Dr. Balakrishnan was Director of Applications from 1995 to 1997 at Measurex Corporation, a company that delivered mission critical real-time control systems for discrete and continuous manufacturing. At Measurex, in various roles, Dr. Balakrishnan developed and introduced market leading products in the US, Europe, Asia, Japan, and the Americas. Dr. Balakrishnan holds Ph.D. and M.Sc. degrees from Stanford University and a B.Eng. degree from the University of Madras. He was also a recipient of the very competitive national science talent scholarship awarded by the Government of India for promising science scholars. Dr. Balakrishnan holds 14 domestic and international patents in various areas of technology.- Ramesh Balakrishnan自2022年7月起担任Uphealth，Inc.总裁兼首席战略官。他之前曾担任Uphealth，Inc.的首席执行官，从业务合并结束到2022年7月，他转任现职。在此之前，Balakrishnan博士自2020年11月起担任UpHealth控股的联席首席执行官，直至合并完成，同时也是Thrasys公司的首席执行官。Thrasys是UpHealth控股的子公司，为综合护理管理提供技术平台和应用程序，从他于2002年3月成立该公司，直至业务合并结束。在创立Thrasys之前，Balakrishnan博士于1998年与他人共同创立了ePropose，Inc.，这是一家开创独特合作技术的技术公司。ePropose，Inc.于2001年与全球最大的私人控股公司Cargill，Inc.合并为一家合资企业。从1997年到1999年，Balakrishnan博士在Asyst Technologies担任软件部副总裁，负责软件部门的总体损益，并为全球半导体行业推出创新的解决方案。Asyst Technologies的客户代表了世界上一些最大的半导体制造厂，包括台湾半导体制造公司。在加入Asyst Technologies之前，Balakrishnan博士曾于1995年至1997年在Measurex公司担任应用总监，该公司提供用于离散和连续制造的关键任务实时控制系统。在Measurex公司，Balakrishnan博士以不同的角色开发和介绍了美国、欧洲、亚洲、日本和美洲市场领先的产品。Balakrishnan博士拥有斯坦福大学的博士和理学硕士学位，以及马德拉斯大学的工程学士学位。他还获得了印度政府为有前途的科学学者颁发的极具竞争力的国家科学人才奖学金。Balakrishnan博士在各个技术领域拥有14项国内和国际专利。
- Ramesh Balakrishnan has served as Uphealth, Inc.'s President and Chief Strategy Officer since July 2022. He previously served as Uphealth, Inc.'s Chief Executive Officer from the closing of the Business Combinations until July 2022 when he transitioned to his current role. Prior to then, Dr. Balakrishnan served as Co-Chief Executive Officer of UpHealth Holdings from November 2020 until the closing of the Business Combinations, and was also the Chief Executive Officer of Thrasys, Inc. "Thrasys", a subsidiary of UpHealth Holdings that delivers technology platforms and applications for integrated care management, from its formation by him in March 2002 until the closing of the Business Combinations. Prior to founding Thrasys, Dr. Balakrishnan co-founded ePropose, Inc., a technology company that pioneered a unique technology for collaboration, in 1998. ePropose, Inc. was merged into a joint venture with Cargill, Inc. - the world's largest privately held company - in 2001. From 1997 to 1999 Dr. Balakrishnan was Vice President of Software at Asyst Technologies where he was responsible for overall profit and loss for the software division, and the launch of innovative solutions for the global semiconductor industry. Asyst Technologies' customers represented some of the largest semiconductor fabrication plants in the world including Taiwan Semiconductor Manufacturing Corporation. Prior to joining Asyst Technologies, Dr. Balakrishnan was Director of Applications from 1995 to 1997 at Measurex Corporation, a company that delivered mission critical real-time control systems for discrete and continuous manufacturing. At Measurex, in various roles, Dr. Balakrishnan developed and introduced market leading products in the US, Europe, Asia, Japan, and the Americas. Dr. Balakrishnan holds Ph.D. and M.Sc. degrees from Stanford University and a B.Eng. degree from the University of Madras. He was also a recipient of the very competitive national science talent scholarship awarded by the Government of India for promising science scholars. Dr. Balakrishnan holds 14 domestic and international patents in various areas of technology.
- Martin S. A. Beck
自2021年6月业务合并完成以来，Martin S. A. Beck一直担任Uphealth，Inc.的Chief Financial Officer。Beck先生自2018年10月起担任Sikich Corporate Finance，LLC的董事总经理，自2003年起担任私人投资公司Rewi Enterprises，LLC的创始人兼总裁。Beck先生于2009年10月至2016年1月担任MAT Capital，LLC的联合创始人兼董事总经理。Beck先生于2007年1月至2009年8月担任Macquarie Capital Advisors的董事，主要负责并购和主要交易。在此之前，从2000年5月开始，贝克先生在摩根大通担任执行董事，专门从事工业部门的兼并和收购。Beck先生还于2009年10月至2015年5月担任潍柴动力公司董事总经理，领导国际企业发展。Beck先生在纽约大学获得工商管理硕士学位，在西北大学法学院获得法学博士学位，在普林斯顿大学获得经济学文学士学位。
Martin S. A. Beck has served as Uphealth, Inc.'s Chief Financial Officer since the closing of the Business Combinations in June 2021. Mr. Beck has served as a Managing Director at Sikich Corporate Finance, LLC since October 2018 and as the founder and President of Rewi Enterprises, LLC, a private investment firm, since 2003. Mr. Beck served as a co-founder and Managing Director of MAT Capital, LLC from October 2009 to January 2016. Mr. Beck was a Director at Macquarie Capital Advisors from January 2007 to August 2009 where he focused on mergers and acquisitions and principal transactions. Before then, beginning in May 2000 Mr. Beck was an Executive Director at J.P. Morgan, where he specialized in mergers and acquisitions in the industrials sectors. Mr. Beck also served as Managing Director of Weichai Power Co. from October 2009 to May 2015 where he led International Corporate Development. Mr. Beck received a Master of Business Administration from New York University, a J.D. from Northwestern University School of Law, and a Bachelor of Arts in Economics from Princeton University.- 自2021年6月业务合并完成以来，Martin S. A. Beck一直担任Uphealth，Inc.的Chief Financial Officer。Beck先生自2018年10月起担任Sikich Corporate Finance，LLC的董事总经理，自2003年起担任私人投资公司Rewi Enterprises，LLC的创始人兼总裁。Beck先生于2009年10月至2016年1月担任MAT Capital，LLC的联合创始人兼董事总经理。Beck先生于2007年1月至2009年8月担任Macquarie Capital Advisors的董事，主要负责并购和主要交易。在此之前，从2000年5月开始，贝克先生在摩根大通担任执行董事，专门从事工业部门的兼并和收购。Beck先生还于2009年10月至2015年5月担任潍柴动力公司董事总经理，领导国际企业发展。Beck先生在纽约大学获得工商管理硕士学位，在西北大学法学院获得法学博士学位，在普林斯顿大学获得经济学文学士学位。
- Martin S. A. Beck has served as Uphealth, Inc.'s Chief Financial Officer since the closing of the Business Combinations in June 2021. Mr. Beck has served as a Managing Director at Sikich Corporate Finance, LLC since October 2018 and as the founder and President of Rewi Enterprises, LLC, a private investment firm, since 2003. Mr. Beck served as a co-founder and Managing Director of MAT Capital, LLC from October 2009 to January 2016. Mr. Beck was a Director at Macquarie Capital Advisors from January 2007 to August 2009 where he focused on mergers and acquisitions and principal transactions. Before then, beginning in May 2000 Mr. Beck was an Executive Director at J.P. Morgan, where he specialized in mergers and acquisitions in the industrials sectors. Mr. Beck also served as Managing Director of Weichai Power Co. from October 2009 to May 2015 where he led International Corporate Development. Mr. Beck received a Master of Business Administration from New York University, a J.D. from Northwestern University School of Law, and a Bachelor of Arts in Economics from Princeton University.